No Data
No Data
Trending Industry Today: WUXI XDC Leads Gains In Biotechnology Stocks
BOCOM INTL: Raised WUXI XDC (02268) Target Price to HKD 51. The Industry's high prosperity and the advantages of the CRDMO model continue to drive strong growth in performance.
The management expects capital expenditure to exceed 1.4 billion yuan in 2025 (vs. 1.54 billion yuan in 2024). By the end of 2024, 3.5 billion in Cash and positive operating cash flow will be sufficient to support capacity expansion.
Nomura Adjusts WuXi XDC Cayman's Price Target to HK$49.76 From HK$42.50, Keeps at Buy
WuXi XDC Cayman Posts 277% Profit Increase in 2024
WUXI XDC (02268) announced its 2024 performance, with net profit attributable to shareholders of approximately 1.07 billion yuan, an increase of 277.2% year-on-year.
WUXI XDC (02268) announced its 2024 performance, with revenue of approximately 4.052 billion yuan, a year-on-year increase of 90.8%...
Express News | WuXi XDC Cayman Inc - FY Profit Attributable RMB 1.07 Bln